FDA Approves IV Version Of Smallpox Drug As Monkeypox Emerges

FDA on Thursday (May 19) approved an intravenous version of SIGA Technologies’ smallpox drug TPOXX (tecovirimat), coming as cases of monkeypox -- which is in the same viral family as smallpox -- emerge around the world and in the United States. TPOXX is not FDA-approved to treat monkeypox, but a company official told Inside Health Policy it has been shown to work against the disease. There is no FDA-approved treatment for monkeypox, but there are currently two FDA-approved drugs...